{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:56:53Z","timestamp":1772535413328,"version":"3.50.1"},"reference-count":68,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A novel fibronectin-based protein (Adnectin) HIV-1 inhibitor was generated using<jats:italic>in vitro<\/jats:italic>selection. This inhibitor binds to human CD4 with a high affinity (3.9 nM) and inhibits viral entry at a step after CD4 engagement and preceding membrane fusion. The progenitor sequence of this novel inhibitor was selected from a library of trillions of Adnectin variants using mRNA display and then further optimized for improved antiviral and physical properties. The final optimized inhibitor exhibited full potency against a panel of 124 envelope (gp160) proteins spanning 11 subtypes, indicating broad-spectrum activity. Resistance profiling studies showed that this inhibitor required 30 passages (151 days) in culture to acquire sufficient resistance to result in viral titer breakthrough. Resistance mapped to the loss of multiple potential N-linked glycosylation sites in gp120, suggesting that inhibition is due to steric hindrance of CD4-binding-induced conformational changes.<\/jats:p>","DOI":"10.1128\/aac.00508-17","type":"journal-article","created":{"date-parts":[[2017,6,6]],"date-time":"2017-06-06T00:30:26Z","timestamp":1496709026000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent Anti-HIV Activity"],"prefix":"10.1128","volume":"61","author":[{"given":"David","family":"Wensel","sequence":"first","affiliation":[{"name":"Department of Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongnian","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Virology, Bristol-Myers Squibb, Wallingford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhufang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Virology, Bristol-Myers Squibb, Wallingford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Virology, Bristol-Myers Squibb, Wallingford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caryn","family":"Picarillo","sequence":"additional","affiliation":[{"name":"Department of Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"McDonagh","sequence":"additional","affiliation":[{"name":"Department of Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fabrizio","sequence":"additional","affiliation":[{"name":"Department of Virology, Bristol-Myers Squibb, Wallingford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Cockett","sequence":"additional","affiliation":[{"name":"Department of Virology, Bristol-Myers Squibb, Wallingford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Krystal","sequence":"additional","affiliation":[{"name":"Department of Virology, Bristol-Myers Squibb, Wallingford, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Molecular Discovery Technologies, Bristol-Myers Squibb, Waltham, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000168"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000164"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq261"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00086-10"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/652190"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-015-0133-6"},{"key":"e_1_3_3_8_2","first-page":"57","article-title":"Long live peptides\u2014evolution of peptide half-life extension technologies and emerging hybrid approaches","volume":"15","author":"Swanson RV","year":"2014","unstructured":"Swanson RV . 2014. Long live peptides\u2014evolution of peptide half-life extension technologies and emerging hybrid approaches. Drug Discovery World15:57\u201361.","journal-title":"Drug Discovery World"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzt023"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-61779-931-0_15","volume-title":"Antibody methods and protocols","author":"Jev\u0161evar S","year":"2012","unstructured":"Jev\u0161evar S KusterleM KenigM. 2012. PEGylation of antibody fragments for half-life extension, p 233\u2013246. InProetzelG EbersbachH (ed), Antibody methods and protocols. Humana Press, Totowa, NJ."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/312763a0"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/312767a0"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-111"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.191124098"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118801109"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/31405"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.2.507"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.8.4784-4793.1992"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2010.09.017"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2677"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzq097"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-015-0459-8"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1998.2238"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-396962-0.00006-9"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90600-H"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(94)90013-2"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-5521(02)00187-4"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2005.12.009"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.02.029"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2144\/000112726"},{"key":"e_1_3_3_31_2","first-page":"71","article-title":"Adnectin CT-322 inhibits tumor growth and affects microvascular architecture and function in Colo205 tumor xenografts","volume":"38","author":"Ackermann M","year":"2011","unstructured":"Ackermann M CarvajalIM MorseBA MoretaM O'NeilS KossodoS PetersonJD DelventhalV MarshHN FurfineES KonerdingMA. 2011. Adnectin CT-322 inhibits tumor growth and affects microvascular architecture and function in Colo205 tumor xenografts. Int J Oncol38:71\u201380.","journal-title":"Int J Oncol"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-352"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.2.2.11304"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1411"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-012-9294-9"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2011.11.016"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13361-014-0973-1"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.3.1.14168"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1586\/14789450.2015.1018897"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.214221"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2015.1007954"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12297"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzi050"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1832214100"},{"key":"e_1_3_3_45_2","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.4049\/jimmunol.145.9.2839","article-title":"Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120","volume":"145","author":"Merkenschlager M","year":"1990","unstructured":"Merkenschlager M BuckD BeverleyPC SattentauQJ. 1990. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120. J Immunol145:2839\u20132845.","journal-title":"J Immunol"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01173-10"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000218"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02237-10"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182732746"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000146"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161765"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17111901"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213480696"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X14999160224103908"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1853"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2016.0624"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.5b04268"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph6121507"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000109"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.4.1233"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00453-10"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708325200"},{"key":"e_1_3_3_63_2","volume-title":"Sequence of proteins of immunological interest","author":"Kabat TTW","year":"1983","unstructured":"Kabat TTW BilofskyEAH Reid-MillerM PerryH. 1983. Sequence of proteins of immunological interest. National Institutes of Health, Bethesda, MD."},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.08.005"},{"key":"e_1_3_3_65_2","first-page":"95","article-title":"Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain","volume":"352","author":"Koide A","year":"2007","unstructured":"Koide A KoideS. 2007. Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain. Methods Mol Biol352:95\u2013109.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.18.e83"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02560-15"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01195-13"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt412"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00508-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00508-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T22:37:30Z","timestamp":1692830250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00508-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1128\/AAC.00508-17"],"URL":"https:\/\/doi.org\/10.1128\/aac.00508-17","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"2017-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00508-17"}}